Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$524M |
| 2 |
Peloton Interactive
PTON
|
+$465M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$290M |
| 5 |
Snap
SNAP
|
+$262M |
Top Sells
| 1 |
Zoom
ZM
|
+$965M |
| 2 |
Pinduoduo
PDD
|
+$805M |
| 3 |
AbbVie
ABBV
|
+$794M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$757M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$750M |
Sector Composition
| 1 | Healthcare | 20.82% |
| 2 | Technology | 16.68% |
| 3 | Consumer Discretionary | 11.18% |
| 4 | Communication Services | 10.87% |
| 5 | Consumer Staples | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
First US Bancshares
FUSB
$70.4M
| $1.47M | ﹤0.01% |
163,199
+1,100
| +0.7% | +$9.92K |
|
2302
Gulf Resources
GURE
$9.21M
| $1.47M | ﹤0.01% |
356,686
-8,426
| -2% | -$34.7K |
|
|
CDR
2303
DELISTED
Cedar Realty Trust, Inc
CDR
| $1.46M | ﹤0.01% |
144,489
-82,569
| -36% | -$837K |
|
|
BCYC
2304
Bicycle Therapeutics
BCYC
$490M
| $1.46M | ﹤0.01% |
81,200
+21,700
| +36% | +$390K |
|
|
CDOR
2305
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
| $1.46M | ﹤0.01% |
370,096
+26,700
| +8% | +$105K |
|
2306
Aquestive Therapeutics
AQST
$594M
| $1.45M | ﹤0.01% |
+271,800
| New | +$1.45M |
|
|
RUBY
2307
DELISTED
Rubius Therapeutics, Inc
RUBY
| $1.45M | ﹤0.01% |
190,989
-73,739
| -28% | -$560K |
|
2308
Perma-Pipe International
PPIH
$184M
| $1.45M | ﹤0.01% |
237,893
+10,000
| +4% | +$60.9K |
|
|
FRTA
2309
DELISTED
Forterra, Inc
FRTA
| $1.44M | ﹤0.01% |
83,963
+57,963
| +223% | +$997K |
|
2310
Lightspeed Commerce
LSPD
$1.71B
| $1.44M | ﹤0.01% |
+20,500
| New | +$1.44M |
|
|
AVID
2311
DELISTED
Avid Technology Inc
AVID
| $1.44M | ﹤0.01% |
90,800
+70,452
| +346% | +$1.12M |
|
2312
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$807M
| $1.44M | ﹤0.01% |
+26,800
| New | +$1.44M |
|
2313
Republic Bancorp
RBCAA
$1.48B
| $1.44M | ﹤0.01% |
39,800
-16,900
| -30% | -$610K |
|
2314
NI Holdings
NODK
$281M
| $1.43M | ﹤0.01% |
87,201
-700
| -0.8% | -$11.5K |
|
2315
Uranium Energy
UEC
$5.5B
| $1.43M | ﹤0.01% |
+812,000
| New | +$1.43M |
|
|
BLPH
2316
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $1.43M | ﹤0.01% |
214,299
-34,012
| -14% | -$227K |
|
|
CXP
2317
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $1.42M | ﹤0.01% |
99,200
-46,200
| -32% | -$663K |
|
2318
Forward Industries
FORD
$59.4M
| $1.42M | ﹤0.01% |
77,954
+2,489
| +3% | +$45.3K |
|
2319
Gaia
GAIA
$150M
| $1.42M | ﹤0.01% |
143,598
+19,597
| +16% | +$194K |
|
|
EVOP
2320
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $1.42M | ﹤0.01% |
52,500
-65,300
| -55% | -$1.76M |
|
2321
First Bank
FRBA
$411M
| $1.42M | ﹤0.01% |
150,865
-11,620
| -7% | -$109K |
|
|
VOLT
2322
DELISTED
Volt Information Sciences, Inc.
VOLT
| $1.41M | ﹤0.01% |
798,642
+151,489
| +23% | +$268K |
|
2323
Bank of N.T. Butterfield & Son
NTB
$1.88B
| $1.41M | ﹤0.01% |
45,300
+6,700
| +17% | +$209K |
|
2324
ProQR Therapeutics
PRQR
$218M
| $1.41M | ﹤0.01% |
335,300
+194,300
| +138% | +$816K |
|
|
AXDX
2325
DELISTED
Accelerate Diagnostics
AXDX
| $1.41M | ﹤0.01% |
18,548
+10,868
| +142% | +$824K |
|